| Literature DB >> 29741115 |
Yu-Shuan Chen1,2, Horng-Jyh Harn3, Tzyy-Wen Chiou4.
Abstract
Permanent deficits that occur in memory, sensation, and cognition can result from central nervous system (CNS) trauma that causes dysfunction and/or unregulated CNS regeneration. Some therapeutic approaches are preferentially applied to the human body. Therefore, cell transplantation, one of the therapeutic strategies, may be used to benefit people. However, poor cell viability and low efficacy are the limitations to cell transplantation strategies. Biomaterials have been widely used in several fields (e.g., triggering cell differentiation, guiding cell migration, improving wound healing, and increasing tissue regeneration) by modulating their characteristics in chemistry, topography, and softness/stiffness for highly flexible application. We reviewed implanted biomaterials to investigate the roles and influences of physical/chemical properties on cell behaviors and applications. With their unique molecular features, biomaterials are delivered in several methods and mixed with transplanted cells, which assists in increasing postimplanted biological substance efficiency on cell survival, host responses, and functional recovery of animal models. Moreover, tracking the routes of these transplanted cells using biomaterials as labeling agents is crucial for addressing their location, distribution, activity, and viability. Here, we provide comprehensive comments and up-to-date research of the application of biomaterials.Entities:
Keywords: biomaterials; central nervous system; chemical; implantation; physical
Mesh:
Substances:
Year: 2018 PMID: 29741115 PMCID: PMC6038039 DOI: 10.1177/0963689717732991
Source DB: PubMed Journal: Cell Transplant ISSN: 0963-6897 Impact factor: 4.139
Electric Charge Effect on Cells’ Behavior.
| Cell | Material | Result | Reference |
|---|---|---|---|
| Hippocampal neurons |
EN-CNT Carboxylated-CNT PABS-CNT | Positively charged EN-CNT revealed most cell outgrowth and branching activities |
|
| NSCs |
SWCNTs/PEI PLO | SWCNT/PEI showed comparable results with PLO |
|
| HASMC |
p(PF-co-EG) hydrogel Agmatine-p(PF-co-EG) hydrogel | Agmatine-p(PF-co-EG) enhanced cell attachment |
|
|
MC3T3-E1 3T3 |
HEMA hydrogels MAETAC-grafted HEMA hydrogels SEMA-grafted HEMA hydrogels | Positively charged MAETAC-grafted HEMA hydrogels had best cell adhesion result |
|
| mESCs |
Collagen based PLGA based Chitosan-based scaffolds | Chitosan-based scaffolds had higher cell numbers than those of collagen-based and PLGA-based 3-dimensional scaffolds |
|
| hESCs |
PAA-CNT PMAA-CNT PLO | Both PAA-CNT and PMAA-CNT can increase neurite outgrowth and neuron differentiation of hESCs compared with PLO | |
| mESCs |
Alginate Alginate-Fn Alginate-HA | Alginate or alginate-HA exhibited increased differentiation of neurons |
|
Abbreviations: EN, ethylenediamine; Fn, fibronectin; HA, hyaluronic acid; HASMC, human aortic smooth muscle cell line; HEMA, hydroxyethyl methacrylate; hESCs, human embryonic stem cells; MAETAC, 2-methacryloxy ethyltrimethyl ammonium chloride; mESCs, mouse embryonic stem cells; NSCs, neuronal stem cells; (p(PF-co-EG), poly(propylene fumarate-co-ethylene glycol); (p(PF-co-EG), poly(propylene fumarate-co-ethylene glycol); PAA, poly(acrylic acid); PABS, poly-m-aminobenzene sulfonic acid; PEI, polyethyleneimine; PLGA, poly(lactic-co-glycolic acid); PLO, poly-L-ornithine; PMAA, poly(methacrylic acid); SEMA, sodium 2-sulfoethyl methacrylate; SWCNT, single-walled CNT.
Effect of Stiffness of Materials on Cells’ Behavior.
| Cell | Material | Result | Reference |
|---|---|---|---|
| NIH3T3 | PAA hydrogel (10–10,000 Pa) |
Cell attachment area has positive correlation with stiffness at 10–3000 Pa Cell attachment area has negative correlation with stiffness at 3000–10,000 Pa |
|
| HeLa cells, preosteoblast cells, NIH3T3 |
600 Pa HA 2500 Pa HA 17,000 Pa HA |
All have positive correlation with stiffness |
|
| hNSPCs, HECFC-ECs |
Fibrin/HA (202.3 ± 17.33 Pa) |
Reducing cell death |
|
| MSCs |
0.1–1 kPa PAA hydrogel 8–17 kPa PAA hydrogel 25–40 kPa PAA hydrogel |
Neurons are grown on matrices of ∼E (0.1–1 kPa) Myogenic lineages are grown on matrices of ∼E (8–17 kPa) Osteogenic lineages are grown on matrices of ∼E (25–40 kPa) |
|
| hESCs |
0.7 KPa PAA hydrogel 3 KPa PAA hydrogel 10 KPa PAA hydrogel |
10 kPa maintains the stemness of the cells for at least 60 days |
|
Abbreviations: HA, hyaluronic acid; HECFC-ECs, human cord blood–derived endothelial cells; hESCs, human embryonic stem cells; hNSPCs, human neural stem progenitor cells; MSCs, mesenchymal stem cells; PAA, polyacrylamide.
Effect of Topography of Materials on Cells’ Behavior.
| Cell | Material | Result | Reference |
|---|---|---|---|
| hNSCs |
300 × 300 × 200 μm (l × w, s) 50 × 50 × 50 μm (l × w, s) 5 × 5 × 5 μm (l × w, s) |
300 × 300 × 200 μm and 5 × 5 × 5 μm (l × w, s) promote the proliferation and differentiation of cells |
|
| hMSCs |
350-nm-width lines 250-nm-width lines |
350-nm lines resulted in spontaneous neurogenic differentiation 250-nm-width lines directed toward both neurogenic and myogenic differentiation | |
| hMSCs |
40/30 μm (W/S) 20/40 μm (W/S) |
40/30 μm guided neuronal lineage growth 20/40 μm was reported to guide myogenic lineage differentiation | |
| hNSCs |
300 × 300 × 200 μm (l × w × s) 50 × 50 × 50 μm (l × w ×s) 5 × 5 × 5 μm (l × w × s) |
300 × 300 × 200 μm and 5 × 5 × 5 μm (l × w × space) promote the proliferation and differentiation of cells 30-μm and 5-μm line patterns allow cells to adhere on the surface 5-μm line pattern allows one cell to adhere on the surface |
|
| L292 cells hMSCs |
10-µm groove on hydrogel |
Improvement in cell adhesion |
|
|
Lamellar wrinkles PHEMA hydrogel Hexagonal wrinkles PHEMA hydrogel |
Lamellar wrinkles promoting cells into an osteogenic lineage differentiation Hexagonal wrinkles promoting cells into an adipocyte lineage |
| |
| miPSCs |
80- to 120-μm pore size 45 to 80-μm pore size 25 to 45-μm pore size |
6 times increase of cell density in group of 80-120 μm porosity 5 times increase of cell density in group of 45-80 and 24-45 μm porosity Gene expression of SOX2 and Otx2 decreased with porosity Protein expressions of SOX2 and PAX6 decreased with porosity |
|
| hiPSC-NPs |
150-μm pore size 100-μm pore size 25-μm pore size |
Length of cell infiltration: group of 25 > 100 > 150-μm pore size |
|
Abbreviations: hiPSC-NPs, human induced pluripotent stem cell–derived neural progenitors; hMSCs, human mesenchymal stem cells; hNSCs, human neural stem cells; l × w, s, length × width, space; miPSCs, mouse induced pluripotentstem cells; PHEMA, poly(2-hydroxyethyl methacrylate); W/S, width/spacing.
Figure 1.Beneficial effects of biomaterials on cellular behavior and biology through the physical/chemical properties of biomaterials.
Effect of Chemistry of Materials Postimplantation.
| Purpose | Applied Site | Materials | Type | Cell | Evidence | Ref |
|---|---|---|---|---|---|---|
| Angiogenesis scaffold | Cerebral cortex | Gelatin/GPSM/bFGF/EGF | Block scaffold | — |
Integrity of the brain shape The scaffold remained for 60 days in the brain Newly produced cells Expressions of GFAP, Iba1, and NAGO |
|
| CNS regeneration scaffold | Cerebrum | HA-IKVAV | Injectable hydrogel | — | Host cell invasion into scaffold |
|
| Brain trauma scaffold | Cerebral cortex | Collagen-GAGs | Injectable hydrogel | — |
7-fold increase of migratory cells and NPCs at 21 days Fewer inflammatory cell BDNF and GDNF were increased |
|
| Generation of cortical neurons | Rodent brain | PEAs/Wnt3A/BM P4/cyclopam ine | Injectable particles | — |
Released for 1 month in vitro Promoted cortical differentiation of cells in vitro Did not evoke a significant inflammatory response in vivo |
|
| SCI scaffold | Spinal cord |
Microfiber s/collagen Microfiber s/chitosan Microfiber s/fibrin | Block scaffold | Mice NS/PCs |
Cell survival: microfibers/collagen > microfibers/chitosan > microfibers/fibrin Scar formation: microfibers/collagen > microfibers/chitosan > microfibers/fibrin Neural lineages in microfibers/collagen: astrocytes > oligodendrocytes > neurons |
|
| TBI scaffold | Cortex | Collagen type I | Injectable hydrogel | hMSCs |
Enhanced by 79% in the target site at 12 hours mNSS and Morris water maze are improved at 28 days Higher differentiated neuronal, oligodendrocyte, and astrocyte cells of hMSCs in hydrogel group than those of cell-only treatment |
|
| TBI scaffold | Cortex |
Laminin/collagen type I Fibronecti n/collagen type I | Injectable hydrogel | NSCs |
Highest implanted cell survival in laminin-based scaffold Most improvement of cognitive behavior in laminin-based scaffold |
|
| SCI scaffold | Spinal cord | HAMC-RGD/PDGF-A | Injectable hydrogel | hiPSCs-OPC |
Higher cell survival in hydrogel (46%) than in media (29%) More migrated cells in hydrogel than in media by 33% Reduced cystic cavitation area by 88% Attenuated teratoma formation in hydrogel vs. those in media |
|
| Stroke brain repair | Brain |
HA hydrogels R-Y-I/HA hydrogels Y-I/BDNF, BMP-4/HA hydrogels | Injectable hydrogel | iPS-NPC |
R-Y-I/HA hydrogels promote iPS-NPCs differentiated into neurons (NF200) in vivo Y-I/BDNF, BMP-4/HA hydrogels promote cell proliferation (Ki-67) and astrocytic differentiation (GFAP) in vivo |
|
| Dopamine secretion | Brain | Agarose/PSS a | Injectable particles | PC12 |
The encapsulated cells survived at least for 5 weeks The encapsulated cell necrosis was not apparent Similarity of expression of GFAP around encapsulation cell gel particles and injection tract |
|
| Anti-Aβ antibody secretion | SC | PEG plus 0.45-μm porous membranes | Device implantation | Chimeri c-C2C12 |
Long-term survival of encapsulated cells over more than 10 months in immunocompetent allogeneic recipients Aβ 40 and Aβ 42 levels decreased Amyloid plaque burden decreased Preventing phospho-tau pathology in the hippocampus |
|
| Neovascularization | Stroke brain | VEGF/PLG A | Injectable particles | hNSCs | More angiogenesis was found in microparticle-released VEGF than in microparticles without VEGF |
|
Abbreviations: Aβ, amyloid-β; BDNF, brain-derived neurotrophic factor; GAGs, glycosaminoglycans; GDNF, glial cell line–derived neurotrophic factor; GPSM, 3-(glycidoxypropyl) trimethoxysilane; HA, hyaluronic acid; HAMC, hyaluronan and methylcellulose; hiPSCs-OPCs, human induced pluripotent stem cells–derived oligodendrocyte progenitor cells; hMSCs, human mesenchymal stem cells; hNSCs, human neural stem cells; iPS-NPC, human induced pluripotent neural precursor; mNSS, modified neurological severity scores; NS/PCs, neural stem/progenitor cells; PEAs, poly(ester amides); PEG, polyethylene glycol; PLGA, poly(D,L-lactic acid-co-glycolic acid); PSSa, poly-(styrene sulfonic acid); SC, subcutaneous; SCI, spinal cord injury; TBI, traumatic brain injury; VEGF, vascular endothelial growth factor.
Effect of Stiffness of Materials Postimplantation.
| Purpose | Applied site | Materials | Type | Cell | Evidence | Reference |
|---|---|---|---|---|---|---|
| Brain inflammation | Brain | PAA gel: - G′ = 30 kPa - G′ = 100 Pa | Block scaffold | —a | Softer material has less inflammatory gene expression postimplantation |
|
| Brain stroke repair | Brain stroke | HA gels: - G′ = 100 Pa - G′ = 350 Pa - G′ = 1000 Pa | Injectable scaffold | —a |
Volume of gel remaining in the brain: 1000 Pa > 350 Pa >100 Pa HA gels 350 Pa HA gel with the lowest remaining volume of infarcted tissue |
|
| SCI scaffold | Spinal cord | 50:50 PLGA/PLGA-PLS | Block scaffold | mNSCs |
Functional recovery: scaffold/cells > scaffold >> cells > nontreatment group Reducing formation of glial scar (GFAP) in scaffold/cells and scaffold group New formation of NF of host origin in scaffold/cells and scaffold group |
|
| HI scaffold | HI brain injury | PGA scaffold | Block scaffold | mNSCs |
Parenchymal loss was dramatically reduced and filled by scaffold plus cells complex Blood vessel and NF formation of exogenous cell by scaffold plus cells complex Mononuclear cell infiltration and astroglial formation minimized by scaffold plus cells complex |
|
| Cell survival | TBI | G′ = 0.8 Pa (laminin based) G′ = 20 Pa (fibronectin based) | Injectable scaffold | NSCs | Highest survival of implanted cell in softer material |
|
Abbreviations: HA, hyaluronic acid; HI, hypoxic-ischemic; mNSCs, murine neural stem cells; NF, neurofilament; NSCs, neural stem cells; PAA, poly(acrylic acid); PLGA, poly(lactic-co-glycolic acid); PLS, poly-L-lysine; SCI, spinal cord injury.
aNot applied.
Effect of Topography of Materials Postimplantation.
| Purpose | Applied Site | Materials | Type | Cell | Evidence | Reference |
|---|---|---|---|---|---|---|
| Premade neural network transplantation | Cortical tissue | Premade neural cell network by PDMS | Block Scaffold free premade neural network | Rat cerebral cortices |
Highly orderly neural structure as in PDMS template with condition of 100, 100, and 200 mm (diameter, depth, and distance) Spontaneous [Ca2]i responses Synaptic connections between transplanted and host cells |
|
| Restore lost long-distance axonal pathways | Rat brain | CMC/agarose/ECM/cells | Block scaffold | Cerebral cortical neurons |
An axonal cytoarchitecture created Facilitated robust neuronal viability (22 days in vitro) Minimally invasive implantation |
|
Abbreviations: CMC, carboxymethyl cellulose; ECM, extracellular matrix.
Advantages and Disadvantages of Various Delivery-Type Biomaterials.
| Advantages | Disadvantages | |
|---|---|---|
| Injectable hydrogels |
Easy to mix with transplanted cells Easy to mix with hydrophilic therapeutic agents Easy to handle in surgical process Easy to simulate mechanical strength of soft tissue |
Shorter remaining time in body Limitation in simulating a higher mechanical strength of hard tissue |
| Injectable particles |
Controlled release of trophic factors or therapeutic agents Easy to handle in surgical process |
Lower protection in delivered cells in the host |
| Block-type materials |
Long-term remaining time in body Easy to simulate a higher mechanical strength of hard tissue |
Requiring bigger surgical area |
Development of Cell Labeling Tracker Applied in the Central Nervous System.
| Application | Labeling Agent | Cell No./Delivery Route | Instrument | Outcome | Reference |
|---|---|---|---|---|---|
| Stroke model | Fluorescent plus magnetite nanocluster | 5 × 105 mBM-MSCs/IC | T2-weighted FSE sequence MRI |
The sizes of labeling agent are 80 ± 10 nm Above 85% cell viability Iron payload for MSC is 18.42 ± 1.7 pg/cell Sensitive enough for monitoring the migration of a small number of cells Labeling does not affect MSC functions |
|
| Stroke model | Fluorescent plus mesoporous silica-coated SPIONs (fmSiO4@SPIONs) |
5 × 105 C17.2 cells/IC 1 × 106 C17.2 cells/IV | T2-weighted SE sequence MRI |
The size of the labeling agent is 50 nm Above 85% cell viability Iron payload for MSC is 10 pg/cell Sensitive for monitoring the cells injected from the intravenous to ischemic hemisphere Migrated labeled cells have cell function with highly expressed nestin |
|
| Stroke model | MRI/SPECT/fluorescent tri-modal probe (125I-fSiO4@SPIOs) |
1 × 106 MSCs/IC 1 × 106 MSCs/IV | T2-weighted FSE sequence combined with SPECT | Quantifiable and real-time visualization of implanted cells: 35% of intracerebrally injected MSCs migrate to the lesion area at 14 days 90% of intravenously injected MSCs trapped in the lung at 14 days |
|
| Stroke model | 19F-MRI contrast agent with fluorescence dye | 3.75×106 hNSCs/IC | T2-weighted MSME MRI combined with diffusion SMES sequence MRI |
Above 75% cell viability after labeling Injected biomaterials and normal cells are distinguishable |
|
Abbreviations: FSE, fast spin echo; hNSCs, human neural stem cells; IC, intracerebrally; IV, intravenously; mBM-MSCs, mouse bone morrow mesenchymal stem cells; MRI, magnetic resonance imaging; MSCs, mesenchymal stem cells; MSME, multislice multiecho sequence; SE, spin echo; SMES, stimulated multiecho trace; SPECT, single-photon emission computed tomography.